Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? (2019)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.dsx.2019.05.034
- Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; DOENÇAS CARDIOVASCULARES; FATORES DE TRANSCRIÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Diabetes & metabolic syndrome-clinical research & reviews
- ISSN: 1871-4021
- Volume/Número/Paginação/Ano: v. 13, n. 4, p. 2723-2725, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
FRUCHART, Jean-Charles et al. Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?. Diabetes & metabolic syndrome-clinical research & reviews, v. 13, n. 4, p. 2723-2725, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.dsx.2019.05.034. Acesso em: 21 maio 2024. -
APA
Fruchart, J. -C., Santos Filho, R. D. dos, Yamashita, S., & Libby, P. (2019). Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? Diabetes & metabolic syndrome-clinical research & reviews, 13( 4), 2723-2725. doi:10.1016/j.dsx.2019.05.034 -
NLM
Fruchart J-C, Santos Filho RD dos, Yamashita S, Libby P. Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? [Internet]. Diabetes & metabolic syndrome-clinical research & reviews. 2019 ; 13( 4): 2723-2725.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.dsx.2019.05.034 -
Vancouver
Fruchart J-C, Santos Filho RD dos, Yamashita S, Libby P. Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? [Internet]. Diabetes & metabolic syndrome-clinical research & reviews. 2019 ; 13( 4): 2723-2725.[citado 2024 maio 21 ] Available from: https://doi.org/10.1016/j.dsx.2019.05.034 - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Informações sobre o DOI: 10.1016/j.dsx.2019.05.034 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
